Download BRECT collaborative publications 2010

BRECT collaborative publications 2010-present
Original research publications (131)
2015
1.
Brand, Judith S., Jingmei Li, Keith Humphreys, Robert Karlsson, Mikael Eriksson, Emma Ivansson,
Per Hall, and Kamila Czene. “Identification of Two Novel Mammographic Density Loci at
6Q25.1.” Breast Cancer Research: BCR 17, no. 1 (June 3, 2015): 75. doi:10.1186/s13058-0150591-2.
2.
Cheddad, Abbas, Kamila Czene, Per Hall, and Keith Humphreys. “Pectoral Muscle Attenuation as a
Marker for Breast Cancer Risk in Full-Field Digital Mammography.” Cancer Epidemiology,
Biomarkers & Prevention: A Publication of the American Association for Cancer Research,
Cosponsored by the American Society of Preventive Oncology 24, no. 6 (June 2015): 985–91.
doi:10.1158/1055-9965.EPI-14-1362.
3.
Evans, D. Gareth, Jean Abraham, Helena Earl, Christopher J. Poole, Louise Hiller, Janet A. Dunn,
Sarah Bowden et al., with Pirie, Ailith, Qi Guo, Peter Kraft, Sander Canisius, Diana M. Eccles,
Nazneen Rahman, Heli Nevanlinna et al., kConFab Investigators and Javier Benitez, M. Pilar
Zamora, Jose Ignacio Arias Perez, Primitiva Menéndez, Anna Jakubowska, Jan Lubinski, Jacek
Gronwald, et al., NBCS Investigators. “Common Germline Polymorphisms Associated with Breast
Cancer-Specific Survival.” Breast Cancer Research: BCR 17, no. 1 (2015): 58. doi:10.1186/s13058015-0570-7.
4.
Giles, Graham G., Hermann Brenner, Peter A. Fasching, Georgia Chenevix-Trench, John Hopper,
Javier Benítez, Angela Cox et al., with Rudolph, Anja, Roger L. Milne, Thérèse Truong, Julia A.
Knight, Petra Seibold, Dieter Flesch-Janys, Sabine Behrens et al., kConFab Investigators, AOCS
Group, and Lothar Häberle, Matthias W. Beckmann, Arif B. Ekici, Aida Karina Dieffenbach,
Volker Arndt, Christa Stegmaier, Catriona McLean, et al., GENICA-Network. “Investigation of
Gene-Environment Interactions between 47 Newly Identified Breast Cancer Susceptibility Loci and
Environmental Risk Factors.” International Journal of Cancer. Journal International Du Cancer
136, no. 6 (March 15, 2015): E685–96. doi:10.1002/ijc.29188.
5.
He, Wei, Fang Fang, Catherine Varnum, Mikael Eriksson, Per Hall, and Kamila Czene. “Predictors
of Discontinuation of Adjuvant Hormone Therapy in Patients With Breast Cancer.” Journal of
Clinical Oncology: Official Journal of the American Society of Clinical Oncology 33, no. 20 (July
10, 2015): 2262–69. doi:10.1200/JCO.2014.59.3673.
6.
Holm, Johanna, Keith Humphreys, Jingmei Li, Alexander Ploner, Abbas Cheddad, Mikael Eriksson,
Sven Törnberg, Per Hall, and Kamila Czene. “Risk Factors and Tumor Characteristics of Interval
Cancers by Mammographic Density.” Journal of Clinical Oncology: Official Journal of the
American Society of Clinical Oncology 33, no. 9 (March 20, 2015): 1030–37.
doi:10.1200/JCO.2014.58.9986.
7.
Johansson, Henrik J., Betzabe C. Sanchez, Jenny Forshed, Olle Stål, Helena Fohlin, Rolf
Lewensohn, Per Hall, Jonas Bergh, Janne Lehtiö, and Barbro K. Linderholm. “Proteomics Profiling
Identify CAPS as a Potential Predictive Marker of Tamoxifen Resistance in Estrogen Receptor
Positive Breast Cancer.” Clinical Proteomics 12, no. 1 (2015): 8. doi:10.1186/s12014-015-9080-y.
8.
Klevebring, Daniel, Johan Lindberg, Julia Rockberg, Camilla Hilliges, Per Hall, Maria Sandberg,
and Kamila Czene. “Exome Sequencing of Contralateral Breast Cancer Identifies Metastatic
Disease.” Breast Cancer Research and Treatment 151, no. 2 (June 2015): 319–24.
doi:10.1007/s10549-015-3403-6.
9.
Koitsalu, Marie, Mirjam A. G. Sprangers, Martin Eklund, Kamila Czene, Per Hall, Henrik
Grönberg, and Yvonne Brandberg. “Public Interest in and Acceptability of the Prospect of RiskStratified Screening for Breast and Prostate Cancer.” Acta Oncologica (Stockholm, Sweden), May
20, 2015, 1–7. doi:10.3109/0284186X.2015.1043024.
10. Lambrechts, Diether, Hans Wildiers, Jenny Chang-Claude, Petra Seibold, Fergus J. Couch, Janet E.
Olson, Irene L. Andrulis et al., with Fagerholm, Rainer, Marjanka K. Schmidt, Sofia Khan, Sajjad
Rafiq, William Tapper, Kristiina Aittomäki, Dario Greco, et al., kConFab Investigators. “The SNP
rs6500843 in 16p13.3 Is Associated with Survival Specifically among Chemotherapy-Treated
Breast Cancer Patients.” Oncotarget 6, no. 10 (April 10, 2015): 7390–7407.
11. Li, J., J. Holm, J. Bergh, M. Eriksson, H. Darabi, L. S. Lindström, S. Törnberg, P. Hall, and K.
Czene. “Breast Cancer Genetic Risk Profile Is Differentially Associated with Interval and ScreenDetected Breast Cancers.” Annals of Oncology: Official Journal of the European Society for
Medical Oncology / ESMO 26, no. 3 (March 2015): 517–22. doi:10.1093/annonc/mdu565.
12. Lindblom, Annika, Jeroen Depreeuw, Matthieu Moisse, Jenny Chang-Claude, Anja Rudolph,
Fergus J. Couch, Janet E. Olson et al., with Carvajal-Carmona, Luis G., Tracy A. O’Mara, Jodie N.
Painter, Felicity A. Lose, Joe Dennis, Kyriaki Michailidou, Jonathan P. Tyrer et al., National Study
of Endometrial Cancer Genetics Group (NSECG), Australian National Endometrial Cancer Study
Group (ANECS), Nicholas Wentzensen, Peter A. Fasching, Alexander Hein, Matthias W.
Beckmann, Stefan P. Renner, Thilo Dörk, Peter Hillemanns, et al., RENDOCAS, Per Hall, Kamila
Czene, Jianjun Liu, Jingmei Li, John L. Hopper, and Melissa C. Southey, Australian Ovarian Cancer
Study (AOCS), and Arif B. Ekici, Matthias Ruebner, Nichola Johnson, Julian Peto, Barbara
Burwinkel, Frederik Marme, Hermann Brenner, Aida K. Dieffenbach, Alfons Meindl, and Hiltrud
Brauch, GENICA Network. “Candidate Locus Analysis of the TERT-CLPTM1L Cancer Risk
Region on Chromosome 5p15 Identifies Multiple Independent Variants Associated with
Endometrial Cancer Risk.” Human Genetics 134, no. 2 (February 2015): 231–45.
doi:10.1007/s00439-014-1515-4.
13. Lindblom, Annika, Jeroen Depreeuw, Matthieu Moisse, Jenny Chang-Claude, Anja Rudolph,
Fergus J. Couch, Janet E. Olson et al., with Painter, Jodie N., Tracy A. O’Mara, Jyotsna Batra,
Timothy Cheng, Felicity A. Lose, Joe Dennis, Kyriaki Michailidou et al., National Study of
Endometrial Cancer Genetics Group (NSECG), CHIBCHA Consortium, Ma Magdalena Echeverry
De Polanco, Monica Sans, Angel Carracedo, Sergi Castellvi-Bel, Augusto Rojas-Martinez, Erika
Santos, Manuel R. Teixeira et al., Australian National Endometrial Cancer Study Group (ANECS),
Grant W. Montgomery, Penelope M. Webb, Rodney J. Scott, Mark McEvoy, John Attia, Elizabeth
Holliday, Nicholas G. Martin, et al., RENDOCAS, Per Hall, Kamila Czene, Jianjun Liu, Jingmei Li,
John L. Hopper, and Melissa C. Southey, Australian Ovarian Cancer Study (AOCS), and Arif B.
Ekici, Matthias Ruebner, Nicola Johnson, Julian Peto, Barbara Burwinkel, Frederik Marme,
Hermann Brenner, Aida K. Dieffenbach, Alfons Meindl, and Hiltrud Brauch, GENICA Network.
“Fine-Mapping of the HNF1B Multicancer Locus Identifies Candidate Variants That Mediate
Endometrial Cancer Risk.” Human Molecular Genetics 24, no. 5 (March 1, 2015): 1478–92.
doi:10.1093/hmg/ddu552.
14. Linn, Sabine, Sten Cornelissen, Sandra Alexandra J. van den Broek, Daehee Kang, Ji-Yeob Choi,
Sue K. Park, Keun-Young Yoo et al., with Lei, Jieping, Anja Rudolph, Kirsten B. Moysich, Sajjad
Rafiq, Sabine Behrens, Ellen L. Goode, Paul P. D. Pharoah, et al., kConFab Investigators.
“Assessment of Variation in Immunosuppressive Pathway Genes Reveals TGFBR2 to Be
Associated with Prognosis of Estrogen Receptor-Negative Breast Cancer after Chemotherapy.”
Breast Cancer Research: BCR 17 (2015): 18. doi:10.1186/s13058-015-0522-2.
15. Mavaddat, Nasim, Paul D. P. Pharoah, Kyriaki Michailidou, Jonathan Tyrer, Mark N. Brook,
Manjeet K. Bolla, Qin Wang, et al. “Prediction of Breast Cancer Risk Based on Profiling with
Common Genetic Variants.” Journal of the National Cancer Institute 107, no. 5 (May 2015).
doi:10.1093/jnci/djv036.
16. Mutvei, Anders Peter, Erik Fredlund, and Urban Lendahl. “Frequency and Distribution of Notch
Mutations in Tumor Cell Lines.” BMC Cancer 15 (2015): 311. doi:10.1186/s12885-015-1278-x.
17. Orr, Nick, Frank Dudbridge, Nicola Dryden, Sarah Maguire, Daniela Novo, Eleni Perrakis, Nichola
Johnson, et al., GENICA Network, kConFab Investigators, and Australian Ovarian Cancer Study
Group. “Fine-Mapping Identifies Two Additional Breast Cancer Susceptibility Loci at 9q31.2.”
Human Molecular Genetics 24, no. 10 (May 15, 2015): 2966–84. doi:10.1093/hmg/ddv035.
18. Phillips, Kelly-Anne, Javier Benitez, M. Pilar Zamora, Jose Ignacio Arias Perez, Primitiva
Menéndez, Anna Jakubowska, Jan Lubinski et al., with Guo, Qi, Marjanka K. Schmidt, Peter Kraft,
Sander Canisius, Constance Chen, Sofia Khan, Jonathan Tyrer, et al., kConFab Investigators.
“Identification of Novel Genetic Markers of Breast Cancer Survival.” Journal of the National
Cancer Institute 107, no. 5 (May 2015). doi:10.1093/jnci/djv081.
19. Radice, Paolo, Paolo Peterlongo, Siranoush Manoukian, Loris Bernard, Natalia V. Bogdanova,
Thilo Dörk, Arto Mannermaa et al., with Michailidou, Kyriaki, Jonathan Beesley, Sara Lindstrom,
Sander Canisius, Joe Dennis, Michael J. Lush, Mel J. Maranian et al., BOCS, Olivia Fletcher, Julian
Peto, Lorna Gibson, Isabel dos-Santos-Silva, Jenny Chang-Claude, Dieter Flesch-Janys, Anja
Rudolph et al., kConFab Investigators, AOCS Group, Annika Lindblom, Sara Margolin, Soo Hwang
Teo, Cheng Har Yip, Nur Aishah Mohd Taib, Gie-Hooi Tan, Maartje J. Hooning et al., NBCS, and
Graham G. Giles, Roger L. Milne, Catriona McLean, Federico Canzian, Dimitrios Trichopoulos,
Petra Peeters, Eiliv Lund, et al., GENICA Network. “Genome-Wide Association Analysis of More
than 120,000 Individuals Identifies 15 New Susceptibility Loci for Breast Cancer.” Nature Genetics
47, no. 4 (April 2015): 373–80. doi:10.1038/ng.3242.
20. Radice, Paolo, Paolo Peterlongo, Giulietta Scuvera, Stefano Fortuzzi, Natalia Bogdanova, Thilo
Dörk, Arto Mannermaa et al., with Kabisch, Maria, Justo Lorenzo Bermejo, Thomas Dünnebier,
Shibo Ying, Kyriaki Michailidou, Manjeet K. Bolla, Qin Wang et al., kConFab Investigators,
Australian Ovarian Cancer Study Group, and Christopher A. Haiman, Fredrick Schumacher, Brian
E. Henderson, Loic Le Marchand, Annika Lindblom, Sara Margolin, Maartje J. Hooning, et al.,
GENICA Network. “Inherited Variants in the Inner Centromere Protein (INCENP) Gene of the
Chromosomal Passenger Complex Contribute to the Susceptibility of ER-Negative Breast Cancer.”
Carcinogenesis 36, no. 2 (February 2015): 256–71. doi:10.1093/carcin/bgu326.
21. Saeed, Ahmed A., Guillem Genové, Tian Li, Frank Hülshorst, Christer Betsholtz, Ingemar
Björkhem, and Dieter Lütjohann. “Increased Flux of the Plant Sterols Campesterol and Sitosterol
across a Disrupted Blood Brain Barrier.” Steroids 99, no. Pt B (July 2015): 183–88.
doi:10.1016/j.steroids.2015.02.005.
22. Schoormans, Dounya, Kamila Czene, Per Hall, and Yvonne Brandberg. “The Impact of CoMorbidity on Health-Related Quality of Life in Breast Cancer Survivors and Controls.” Acta
Oncologica (Stockholm, Sweden) 54, no. 5 (May 2015): 727–34.
doi:10.3109/0284186X.2014.998277.
23. ———. “The Impact of Co-Morbidity on Health-Related Quality of Life in Breast Cancer Survivors
and Controls.” Acta Oncologica (Stockholm, Sweden) 54, no. 5 (May 2015): 727–34.
doi:10.3109/0284186X.2014.998277.
24. Stone, Jennifer, Deborah J. Thompson, Isabel Dos Santos Silva, Christopher Scott, Rulla M.
Tamimi, Sara Lindstrom, Peter Kraft, et al. “Novel Associations between Common Breast Cancer
Susceptibility Variants and Risk-Predicting Mammographic Density Measures.” Cancer Research
75, no. 12 (June 15, 2015): 2457–67. doi:10.1158/0008-5472.CAN-14-2012.
25. Trinh, Thang, Mikael Eriksson, Hatef Darabi, Stephanie E. Bonn, Judith S. Brand, Jack Cuzick,
Kamila Czene, Arvid Sjölander, Katarina Bälter, and Per Hall. “Background Risk of Breast Cancer
and the Association between Physical Activity and Mammographic Density.” Breast Cancer
Research: BCR 17, no. 1 (April 2, 2015): 50. doi:10.1186/s13058-015-0565-4.
26. Waisfisz, Quinten, Hanne E. J. Meijers-Heijboer, Muriel A. Adank, Rob B. Van Der Luijt, Per Hall,
Georgia Chenevix-Trench, Alison Dunning, Douglas F. Easton, and Angela Cox with Lin, Wei-Yu,
Nicola J. Camp, Maya Ghoussaini, Jonathan Beesley, Kyriaki Michailidou, John L. Hopper, Carmel
Apicella et al., GENICA Network, Daniel C. Tessier, Daniel Vincent, Francois Bacot, Heli
Nevanlinna, Kristiina Aittomäki, Carl Blomqvist, Sofia Khan et al., kConFab Investigators,
Australian Ovarian Cancer Study Group, and Anna H. Wu, Chiu-Chen Tseng, David Van Den Berg,
Daniel O. Stram, Patrick Neven, Els Wauters, Hans Wildiers, et al., Breast and Ovarian Cancer
Susceptibility (BOCS) Study. “Identification and Characterization of Novel Associations in the
CASP8/ALS2CR12 Region on Chromosome 2 with Breast Cancer Risk.” Human Molecular
Genetics 24, no. 1 (January 1, 2015): 285–98. doi:10.1093/hmg/ddu431.
27. Zeisel, Amit, Ana B. Muñoz-Manchado, Simone Codeluppi, Peter Lönnerberg, Gioele La Manno,
Anna Juréus, Sueli Marques, et al. “Brain Structure. Cell Types in the Mouse Cortex and
Hippocampus Revealed by Single-Cell RNA-Seq.” Science (New York, N.Y.) 347, no. 6226 (March
6, 2015): 1138–42. doi:10.1126/science.aaa1934.
28. Zheng, Wei, Sandra L. Halverson, Martha Shrubsole, Jirong Long, Robert Winqvist, Katri Pylkäs,
Arja Jukkola-Vuorinen et al., with Glubb, Dylan M., Mel J. Maranian, Kyriaki Michailidou, Karen
A. Pooley, Kerstin B. Meyer, Siddhartha Kar, Saskia Carlebur et al., GENICA Network, Heli
Nevanlinna, Taru A. Muranen, Kristiina Aittomäki, Carl Blomqvist, Keitaro Matsuo, Hidemi Ito,
Hiroji Iwata et al., kConFab Investigators, and Anna H. Wu, Chiu-chen Tseng, David Van Den
Berg, Daniel O. Stram, Diether Lambrechts, Hui Zhao, Caroline Weltens, et al., Norwegian Breast
Cancer Study. “Fine-Scale Mapping of the 5q11.2 Breast Cancer Locus Reveals at Least Three
Independent Risk Variants Regulating MAP3K1.” American Journal of Human Genetics 96, no. 1
(January 8, 2015): 5–20. doi:10.1016/j.ajhg.2014.11.009.
2014
29. Boomsma, Dorret I., Michael J. Econs, Kay-Tee Khaw, Ruth J. F. Loos, Mark I. McCarthy, Grant
W. Montgomery, John P. Rice et al., with Perry, John R. B., Felix Day, Cathy E. Elks, Patrick
Sulem, Deborah J. Thompson, Teresa Ferreira, Chunyan He, et al., Australian Ovarian Cancer
Study, GENICA Network, kConFab, LifeLines Cohort Study, InterAct Consortium, and Early
Growth Genetics (EGG) Consortium. “Parent-of-Origin-Specific Allelic Associations among 106
Genomic Loci for Age at Menarche.” Nature 514, no. 7520 (October 2, 2014): 92–97.
doi:10.1038/nature13545.
30. Brand, Judith S., Kamila Czene, John A. Shepherd, Karin Leifland, Boel Heddson, Ann Sundbom,
Mikael Eriksson, Jingmei Li, Keith Humphreys, and Per Hall. “Automated Measurement of
Volumetric Mammographic Density: A Tool for Widespread Breast Cancer Risk Assessment.”
Cancer Epidemiology, Biomarkers & Prevention: A Publication of the American Association for
Cancer Research, Cosponsored by the American Society of Preventive Oncology 23, no. 9
(September 2014): 1764–72. doi:10.1158/1055-9965.EPI-13-1219.
31. Brand, Judith S., Keith Humphreys, Deborah J. Thompson, Jingmei Li, Mikael Eriksson, Per Hall,
and Kamila Czene. “Volumetric Mammographic Density: Heritability and Association with Breast
Cancer Susceptibility Loci.” Journal of the National Cancer Institute 106, no. 12 (December 2014).
doi:10.1093/jnci/dju334.
32. Brenner, Hermann, Aida Karina Dieffenbach, Volker Arndt, Christa Stegmaier, Anthony Swerdlow,
Alan Ashworth, Nick Orr et al., with Khan, Sofia, Dario Greco, Kyriaki Michailidou, Roger L.
Milne, Taru A. Muranen, Tuomas Heikkinen, Kirsimari Aaltonen et al., kConFab Investigators,
Australian Ovarian Cancer Study Group, and Susan Slager, Amanda E. Toland, Christine B.
Ambrosone, Drakoulis Yannoukakos, Annika Lindblom, Sara Margolin, Paolo Radice, et al.,
GENICA Network. “MicroRNA Related Polymorphisms and Breast Cancer Risk.” PloS One 9, no.
11 (2014): e109973. doi:10.1371/journal.pone.0109973.
33. Brüning, Thomas, Yon-Dschun Ko, Carolien H. M. Van Deurzen, John W. M. Martens, Mieke
Kriege, Jonine D. Figueroa, Stephen J. Chanock et al., with Purrington, Kristen S., Seth Slettedahl,
Manjeet K. Bolla, Kyriaki Michailidou, Kamila Czene, Heli Nevanlinna, Stig E. Bojesen et al.,
ABCTB Investigators, Florentia Fostira, George Fountzilas, Irene Konstantopoulou, Brian E.
Henderson, Fredrick Schumacher, Loic Le Marchand, Arif B. Ekici et al., Australian Ovarian
Cancer Study Group, kConFab Investigators, and Rosemary Balleine, Jose Ignacio Arias Perez, M.
Pilar Zamora, Primitiva Menéndez, Alan Ashworth, Michael Jones, Nick Orr, et al., GENICA
Network. “Genetic Variation in Mitotic Regulatory Pathway Genes Is Associated with Breast
Tumor Grade.” Human Molecular Genetics 23, no. 22 (November 15, 2014): 6034–46.
doi:10.1093/hmg/ddu300.
34. Bruzzese, Francesca, Christina Hägglöf, Alessandra Leone, Elin Sjöberg, Maria Serena Roca, Sara
Kiflemariam, Tobias Sjöblom, et al. “Local and Systemic Protumorigenic Effects of Cancer-
Associated Fibroblast-Derived GDF15.” Cancer Research 74, no. 13 (July 1, 2014): 3408–17.
doi:10.1158/0008-5472.CAN-13-2259.
35. Cheddad, Abbas, Kamila Czene, Mikael Eriksson, Jingmei Li, Douglas Easton, Per Hall, and Keith
Humphreys. “Area and Volumetric Density Estimation in Processed Full-Field Digital
Mammograms for Risk Assessment of Breast Cancer.” PloS One 9, no. 10 (2014): e110690.
doi:10.1371/journal.pone.0110690.
36. Cheddad, Abbas, Kamila Czene, John A. Shepherd, Jingmei Li, Per Hall, and Keith Humphreys.
“Enhancement of Mammographic Density Measures in Breast Cancer Risk Prediction.” Cancer
Epidemiology, Biomarkers & Prevention: A Publication of the American Association for Cancer
Research, Cosponsored by the American Society of Preventive Oncology 23, no. 7 (July 2014):
1314–23. doi:10.1158/1055-9965.EPI-13-1240.
37. Colzani, E., A. L. V. Johansson, A. Liljegren, T. Foukakis, M. Clements, J. Adolfsson, P. Hall, and
K. Czene. “Time-Dependent Risk of Developing Distant Metastasis in Breast Cancer Patients
according to Treatment, Age and Tumour Characteristics.” British Journal of Cancer 110, no. 5
(March 4, 2014): 1378–84. doi:10.1038/bjc.2014.5.
38. Dunning, Alison M., Paul Pharoah, Quinten Waisfisz, Hanne Meijers-Heijboer, Andre G.
Uitterlinden, Fernando Rivadeneira, Dan Nicolae, Douglas F. Easton, Nancy J. Cox, and Alice S.
Whittemore with Ahsan, Habibul, Jerry Halpern, Muhammad G. Kibriya, Brandon L. Pierce, Lin
Tong, Eric Gamazon, Valerie McGuire, et al., Familial Breast Cancer Study. “A Genome-Wide
Association Study of Early-Onset Breast Cancer Identifies PFKM as a Novel Breast Cancer Gene
and Supports a Common Genetic Spectrum for Breast Cancer at Any Age.” Cancer Epidemiology,
Biomarkers & Prevention: A Publication of the American Association for Cancer Research,
Cosponsored by the American Society of Preventive Oncology 23, no. 4 (April 2014): 658–69.
doi:10.1158/1055-9965.EPI-13-0340.
39. Ghoussaini, Maya, Stacey L. Edwards, Kyriaki Michailidou, Silje Nord, Richard Cowper-Sal Lari,
Kinjal Desai, Siddhartha Kar, et al., Australian Ovarian Cancer Management Group and Australian
Ovarian Cancer Management Group. “Evidence That Breast Cancer Risk at the 2q35 Locus Is
Mediated through IGFBP5 Regulation.” Nature Communications 4 (2014): 4999.
doi:10.1038/ncomms5999.
40. Inaki, Koichiro, Francesca Menghi, Xing Yi Woo, Joel P. Wagner, Pierre-Étienne Jacques, Yi Fang
Lee, Phung Trang Shreckengast, et al. “Systems Consequences of Amplicon Formation in Human
Breast Cancer.” Genome Research 24, no. 10 (October 2014): 1559–71. doi:10.1101/gr.164871.113.
41. Justenhoven, Christina, Daniela Pentimalli, Sylvia Rabstein, Volker Harth, Anne Lotz, Beate Pesch,
Thomas Brüning, et al. “CYP2B6*6 Is Associated with Increased Breast Cancer Risk.”
International Journal of Cancer. Journal International Du Cancer 134, no. 2 (January 15, 2014):
426–30. doi:10.1002/ijc.28356.
42. Klevebring, Daniel, Mårten Neiman, Simon Sundling, Louise Eriksson, Eva Darai Ramqvist, Fuat
Celebioglu, Kamila Czene, et al. “Evaluation of Exome Sequencing to Estimate Tumor Burden in
Plasma.” PloS One 9, no. 8 (2014): e104417. doi:10.1371/journal.pone.0104417.
43. Klevebring, Daniel, Gustaf Rosin, Ran Ma, Johan Lindberg, Kamila Czene, Juha Kere, Irma
Fredriksson, Jonas Bergh, and Johan Hartman. “Sequencing of Breast Cancer Stem Cell Populations
Indicates a Dynamic Conversion between Differentiation States in Vivo.” Breast Cancer Research:
BCR 16, no. 4 (2014): R72. doi:10.1186/bcr3687.
44. Lindström, L. S., J. Li, M. Lee, Z. Einbeigi, M. Hartman, P. Hall, and K. Czene. “Prognostic
Information of a Previously Diagnosed Sister Is an Independent Prognosticator for a Newly
Diagnosed Sister with Breast Cancer.” Annals of Oncology: Official Journal of the European
Society for Medical Oncology / ESMO 25, no. 10 (October 2014): 1966–72.
doi:10.1093/annonc/mdu270.
45. Lindström, Sara, Deborah J. Thompson, Andrew D. Paterson, Jingmei Li, Gretchen L. Gierach,
Christopher Scott, Jennifer Stone, et al. “Genome-Wide Association Study Identifies Multiple Loci
Associated with Both Mammographic Density and Breast Cancer Risk.” Nature Communications 5
(2014): 5303. doi:10.1038/ncomms6303.
46. McGale, P., C. Taylor, C. Correa, D. Cutter, F. Duane, M. Ewertz, R. Gray, et al. with EBCTCG
(Early Breast Cancer Trialists’ Collaborative Group). “Effect of Radiotherapy after Mastectomy and
Axillary Surgery on 10-Year Recurrence and 20-Year Breast Cancer Mortality: Meta-Analysis of
Individual Patient Data for 8135 Women in 22 Randomised Trials.” Lancet (London, England) 383,
no. 9935 (June 21, 2014): 2127–35. doi:10.1016/S0140-6736(14)60488-8.
47. Morton, Lindsay M., Ethel S. Gilbert, Marilyn Stovall, Flora E. van Leeuwen, Graça M. Dores,
Charles F. Lynch, Per Hall, et al. “Risk of Esophageal Cancer Following Radiotherapy for Hodgkin
Lymphoma.” Haematologica 99, no. 10 (October 2014): e193–96.
doi:10.3324/haematol.2014.108258.
48. Nevanlinna, Heli, Taru A. Muranen, Kristiina Aittomäki, Carl Blomqvist, Natalia V. Bogdanova,
Thilo Dörk, Annika Lindblom et al., with Sawyer, Elinor, Rebecca Roylance, Christos Petridis,
Mark N. Brook, Salpie Nowinski, Efterpi Papouli, Olivia Fletcher, et al., GENICA Network.
“Genetic Predisposition to in Situ and Invasive Lobular Carcinoma of the Breast.” PLoS Genetics
10, no. 4 (April 2014): e1004285. doi:10.1371/journal.pgen.1004285.
49. Ong, Ken K., Joanne M. Murabito, David Karasik, and Anna Murray with Perry, John R. B., YiHsiang Hsu, Daniel I. Chasman, Andrew D. Johnson, Cathy Elks, Eva Albrecht, Irene L. Andrulis et
al., kConFab investigators and Sharon L. R. Kardia, Katherine Kasiman, Julia A. Knight, Jari Lahti,
Debbie A. Lawlor, Patrik K. E. Magnusson, Sara Margolin, et al., ReproGen Consortium. “DNA
Mismatch Repair Gene MSH6 Implicated in Determining Age at Natural Menopause.” Human
Molecular Genetics 23, no. 9 (May 1, 2014): 2490–97. doi:10.1093/hmg/ddt620.
50. Pettersson, Andreas, Rebecca E. Graff, Giske Ursin, Isabel Dos Santos Silva, Valerie McCormack,
Laura Baglietto, Celine Vachon, et al. “Mammographic Density Phenotypes and Risk of Breast
Cancer: A Meta-Analysis.” Journal of the National Cancer Institute 106, no. 5 (May 2014).
doi:10.1093/jnci/dju078.
51. Phillips, Kelly-Anne, Sue-Anne McLachlan, Diether Lambrechts, Bernard Thienpont, Ann Smeets,
Hans Wildiers, Jenny Chang-Claude et al., with Li, Jingmei, Linda S. Lindström, Jia N. Foo, Sajjad
Rafiq, Marjanka K. Schmidt, Paul D. P. Pharoah, Kyriaki Michailidou, et al., kConFab
Investigators. “2q36.3 Is Associated with Prognosis for Oestrogen Receptor-Negative Breast Cancer
Patients Treated with Chemotherapy.” Nature Communications 5 (2014): 4051.
doi:10.1038/ncomms5051.
52. Rosin, G., J. de Boniface, G. M. Karthik, J. Frisell, J. Bergh, and J. Hartman. “Oestrogen Receptors
β1 and Βcx Have Divergent Roles in Breast Cancer Survival and Lymph Node Metastasis.” British
Journal of Cancer 111, no. 5 (August 26, 2014): 918–26. doi:10.1038/bjc.2014.398.
53. Schoeps, Anja, Anja Rudolph, Petra Seibold, Alison M. Dunning, Roger L. Milne, Stig E. Bojesen,
Anthony Swerdlow, et al. “Identification of New Genetic Susceptibility Loci for Breast Cancer
through Consideration of Gene-Environment Interactions.” Genetic Epidemiology 38, no. 1 (January
2014): 84–93. doi:10.1002/gepi.21771.
54. Sovio, U., J. Li, Z. Aitken, K. Humphreys, K. Czene, S. Moss, P. Hall, V. McCormack, and I. dosSantos-Silva. “Comparison of Fully and Semi-Automated Area-Based Methods for Measuring
Mammographic Density and Predicting Breast Cancer Risk.” British Journal of Cancer 110, no. 7
(April 2, 2014): 1908–16. doi:10.1038/bjc.2014.82.
55. Yannoukakos, D., O. Fletcher, N. Johnson, I. dos Santos Silva, J. Peto, F. Marme, B. Burwinkel et
al., with Agarwal, D., S. Pineda, K. Michailidou, J. Herranz, G. Pita, L. T. Moreno, M. R. Alonso et
al., kConFab Investigators, Australian Ovarian Cancer Study Group, M. Hartman, M. Hui, W. Y.
Lim, P. T.-C. Iau, E. Sawyer, I. Tomlinson, M. Kerin et al., GENICA Network, and A. M. Dunning,
M. Shah, I. L. Andrulis, J. A. Knight, G. Glendon, S. Tchatchou, M. K. Schmidt, et al., TNBCC.
“FGF Receptor Genes and Breast Cancer Susceptibility: Results from the Breast Cancer Association
Consortium.” British Journal of Cancer 110, no. 4 (February 18, 2014): 1088–1100.
doi:10.1038/bjc.2013.769.
56. Yannoukakos, Drakoulis, Paul D. P. Pharoah, Per Hall, Javier Benítez, Núria Malats, and Douglas
F. Easton with Milne, Roger L., Jesús Herranz, Kyriaki Michailidou, Joe Dennis, Jonathan P. Tyrer,
M. Pilar Zamora, José Ignacio Arias-Perez et al., kConFab Investigators, Australian Ovarian Cancer
Study Group, Anthony Swerdlow, Alan Ashworth, Nicholas Orr, Minouk Schoemaker, Anna
Jakubowska, Jan Lubinski, Katarzyna Jaworska-Bieniek, et al., GENICA Network, and Fergus J.
Couch, and Amanda E. Toland, TNBCC. “A Large-Scale Assessment of Two-Way SNP
Interactions in Breast Cancer Susceptibility Using 46,450 Cases and 42,461 Controls from the
Breast Cancer Association Consortium.” Human Molecular Genetics 23, no. 7 (April 1, 2014):
1934–46. doi:10.1093/hmg/ddt581.
57. Yannoukakos, Drakoulis, Suleeporn Sangrajrang, James McKay, Xianshu Wang, Janet E. Olson,
Celine Vachon, Kristen Purrington et al., with Milne, Roger L., Barbara Burwinkel, Kyriaki
Michailidou, Jose-Ignacio Arias-Perez, M. Pilar Zamora, Primitiva Menéndez-Rodríguez, David
Hardisson et al., GENICA Network, Irene L. Andrulis, Julia A. Knight, Gord Glendon, and
Sandrine Tchatchou, kConFab Investigators, Australian Ovarian Cancer Study Group, and Keitaro
Matsuo, Hidemi Ito, Hiroji Iwata, Kazuo Tajima, Jingmei Li, Judith S. Brand, Hermann Brenner, et
al., TNBCC. “Common Non-Synonymous SNPs Associated with Breast Cancer Susceptibility:
Findings from the Breast Cancer Association Consortium.” Human Molecular Genetics 23, no. 22
(November 15, 2014): 6096–6111. doi:10.1093/hmg/ddu311.
2013
58. Brand, Judith S., Kamila Czene, Louise Eriksson, Thang Trinh, Nirmala Bhoo-Pathy, Per Hall, and
Fuat Celebioglu. “Influence of Lifestyle Factors on Mammographic Density in Postmenopausal
Women.” PloS One 8, no. 12 (2013): e81876. doi:10.1371/journal.pone.0081876.
59. Chen, Shou-Tung, Jyh-Cherng Yu, Argyrios Ziogas, Vesa Kataja, Veli-Matti Kosma, Arto
Mannermaa, Hoda Anton-Culver et al., with Hein, Rebecca, Dieter Flesch-Janys, Norbert Dahmen,
Lars Beckmann, Sara Lindström, Nils Schoof, Kamila Czene, et al., GENICA Network. “A
Genome-Wide Association Study to Identify Genetic Susceptibility Loci That Modify Ductal and
Lobular Postmenopausal Breast Cancer Risk Associated with Menopausal Hormone Therapy Use:
A Two-Stage Design with Replication.” Breast Cancer Research and Treatment 138, no. 2 (April
2013): 529–42. doi:10.1007/s10549-013-2443-z.
60. Eriksson, Louise, Kamila Czene, Lena Rosenberg, Keith Humphreys, and Per Hall. “Possible
Influence of Mammographic Density on Local and Locoregional Recurrence of Breast Cancer.”
Breast Cancer Research: BCR 15, no. 4 (2013): R56. doi:10.1186/bcr3450.
61. Eriksson, Louise, Kamila Czene, Lena U. Rosenberg, Sven Törnberg, Keith Humphreys, and Per
Hall. “Mammographic Density and Survival in Interval Breast Cancers.” Breast Cancer Research:
BCR 15, no. 3 (2013): R48. doi:10.1186/bcr3440.
62. Frings, Oliver, Martin Augsten, Nicholas P. Tobin, Joseph Carlson, Janna Paulsson, Cristina Pena,
Eleonor Olsson, et al. “Prognostic Significance in Breast Cancer of a Gene Signature Capturing
Stromal PDGF Signaling.” The American Journal of Pathology 182, no. 6 (June 2013): 2037–47.
doi:10.1016/j.ajpath.2013.02.018.
63. Li, Jingmei, Kamila Czene, Hiltrud Brauch, Werner Schroth, Pilar Saladores, Yi Li, Keith
Humphreys, and Per Hall. “Association of CYP2D6 Metabolizer Status with Mammographic
Density Change in Response to Tamoxifen Treatment.” Breast Cancer Research: BCR 15, no. 5
(2013): R93. doi:10.1186/bcr3495.
64. Li, Jingmei, Jia Nee Foo, Nils Schoof, Jajini S. Varghese, Pablo Fernandez-Navarro, Gretchen L.
Gierach, Swee Tian Quek, et al. “Large-Scale Genotyping Identifies a New Locus at 22q13.2
Associated with Female Breast Size.” Journal of Medical Genetics 50, no. 10 (October 2013): 666–
73. doi:10.1136/jmedgenet-2013-101708.
65. Li, Jingmei, Keith Humphreys, Louise Eriksson, Gustaf Edgren, Kamila Czene, and Per Hall.
“Mammographic Density Reduction Is a Prognostic Marker of Response to Adjuvant Tamoxifen
Therapy in Postmenopausal Patients with Breast Cancer.” Journal of Clinical Oncology: Official
Journal of the American Society of Clinical Oncology 31, no. 18 (June 20, 2013): 2249–56.
doi:10.1200/JCO.2012.44.5015.
66. Olswold, Curtis, Susan Slager, Robert Pilarski, Foluso Ademuyiwa, Irene Konstantopoulou,
Nicholas G. Martin, Grant W. Montgomery et al., with Garcia-Closas, Montserrat, Fergus J. Couch,
Sara Lindstrom, Kyriaki Michailidou, Marjanka K. Schmidt, Mark N. Brook, Nick Orr et al., Gene
ENvironmental Interaction and breast CAncer (GENICA) Network, Taru A. Muranen, Kristiina
Aittomäki, Carl Blomqvist, Dario Greco, Tuomas Heikkinen, Hidemi Ito, Hiroji Iwata et al.,
kConFab Investigators, Chiu-Chen Tseng, David Van Den Berg, Daniel O. Stram, Patrick Neven,
Anne-Sophie Dieudonné, Karin Leunen, Anja Rudolph, et al., Familial Breast Cancer Study
(FBCS), and Nazneen Rahman, Hanne Meijers-Heijboer, Andre G. Uitterlinden, and Fernando
Rivadeneira, Australian Breast Cancer Tissue Bank (ABCTB) Investigators. “Genome-Wide
Association Studies Identify Four ER Negative-Specific Breast Cancer Risk Loci.” Nature Genetics
45, no. 4 (April 2013): 392–98, 398e1–2. doi:10.1038/ng.2561.
67. Radice, Paolo, Paolo Peterlongo, Siranoush Manoukian, Bernardo Bonanni, Peter Devilee, Rob A.
E. M. Tollenaar, Caroline Seynaeve et al., with Michailidou, Kyriaki, Per Hall, Anna GonzalezNeira, Maya Ghoussaini, Joe Dennis, Roger L. Milne, Marjanka K. Schmidt et al., Breast and
Ovarian Cancer Susceptibility Collaboration, Olivia Fletcher, Julian Peto, Lorna Gibson, Isabel Dos
Santos Silva, Heli Nevanlinna, Taru A. Muranen, Kristiina Aittomäki et al., Hereditary Breast and
Ovarian Cancer Research Group Netherlands (HEBON), Rob B. van der Luijt, Rebecca Hein,
Norbert Dahmen, Lars Beckman, Alfons Meindl, Rita K. Schmutzler, Bertram Müller-Myhsok et
al., kConFab Investigators, Australian Ovarian Cancer Study Group, and Annika Lindblom, Sara
Margolin, Maartje J. Hooning, Antoinette Hollestelle, Ans M. W. van den Ouweland, Agnes Jager,
Quang M. Bui, et al., GENICA (Gene Environment Interaction and Breast Cancer in Germany)
Network. “Large-Scale Genotyping Identifies 41 New Loci Associated with Breast Cancer Risk.”
Nature Genetics 45, no. 4 (April 2013): 353–61, 361e1–2. doi:10.1038/ng.2563.
68. Rudolph, Anja, Rebecca Hein, Sara Lindström, Lars Beckmann, Sabine Behrens, Jianjun Liu,
Hugues Aschard et al., GENICA Network, Gianluca Severi, Laura Baglietto, Melissa Southey,
Stephen J. Chanock, Jolanta Lissowska, Jonine D. Figueroa, Mikael Eriksson et al., kConFab
Investigators, AOCS Management Group, and Pascal Guénel, Hiltrud Brauch, Graham Giles,
Montserrat García-Closas, Kamila Czene, Georgia Chenevix-Trench, Fergus J. Couch, et al., Breast
Cancer Association Consortium. “Genetic Modifiers of Menopausal Hormone Replacement
Therapy and Breast Cancer Risk: A Genome-Wide Interaction Study.” Endocrine-Related Cancer
20, no. 6 (December 2013): 875–87. doi:10.1530/ERC-13-0349.
69. Sandberg, Maria E. C., Sara Alkner, Mikael Hartman, Sandra Eloranta, Lisa Rydén, Alexander
Ploner, Hans-Olov Adami, Per Hall, and Kamila Czene. “Influence of Radiotherapy for the First
Tumor on Aggressiveness of Contralateral Breast Cancer.” International Journal of Cancer. Journal
International Du Cancer 132, no. 10 (May 15, 2013): 2388–94. doi:10.1002/ijc.27890.
70. Sandberg, Maria E. C., Jingmei Li, Per Hall, Mikael Hartman, Isabel dos-Santos-Silva, Keith
Humphreys, and Kamila Czene. “Change of Mammographic Density Predicts the Risk of
Contralateral Breast Cancer--a Case-Control Study.” Breast Cancer Research: BCR 15, no. 4
(2013): R57. doi:10.1186/bcr3451.
71. Vergote, Ignace, Sandrina Lambrechts, Evelyn Despierre, Harvey A. Risch, Anna González-Neira,
Mary Anne Rossing, Guillermo Pita et al., with Bojesen, Stig E., Karen A. Pooley, Sharon E.
Johnatty, Jonathan Beesley, Kyriaki Michailidou, Jonathan P. Tyrer, Stacey L. Edwards, et al.,
Australian Cancer Study, Australian Ovarian Cancer Study, Kathleen Cuningham Foundation
Consortium for Research into Familial Breast Cancer (kConFab), Gene Environment Interaction and
Breast Cancer (GENICA), Swedish Breast Cancer Study (SWE-BRCA), Hereditary Breast and
Ovarian Cancer Research Group Netherlands (HEBON), Epidemiological study of BRCA1 &
BRCA2 Mutation Carriers (EMBRACE), and Genetic Modifiers of Cancer Risk in BRCA1/2
Mutation Carriers (GEMO). “Multiple Independent Variants at the TERT Locus Are Associated
with Telomere Length and Risks of Breast and Ovarian Cancer.” Nature Genetics 45, no. 4 (April
2013): 371–84, 384e1–2. doi:10.1038/ng.2566.
72. Wu, Anna H., Chiu-chen Tseng, David Van Den Berg, Daniel O. Stram, Diether Lambrechts,
Stephanie Peeters, Ann Smeets et al., with French, Juliet D., Maya Ghoussaini, Stacey L. Edwards,
Kerstin B. Meyer, Kyriaki Michailidou, Shahana Ahmed, Sofia Khan et al., GENICA Network and
Kirsimari Aaltonen, Päivi Heikkilä, Kristiina Aittomäki, Carl Blomqvist, Keitaro Matsuo, Hidemi
Ito, Hiroji Iwata, et al., kConFab Investigators. “Functional Variants at the 11q13 Risk Locus for
Breast Cancer Regulate Cyclin D1 Expression through Long-Range Enhancers.” American Journal
of Human Genetics 92, no. 4 (April 4, 2013): 489–503. doi:10.1016/j.ajhg.2013.01.002.
73. Wu, Anna H., Chiu-Chen Tseng, David Van Den Berg, Daniel O. Stram, Diether Lambrechts,
Bernard Thienpont, Marie-Rose Christiaens et al., with Meyer, Kerstin B., Martin O’Reilly, Kyriaki
Michailidou, Saskia Carlebur, Stacey L. Edwards, Juliet D. French, Radhika Prathalingham et al.,
GENICA Network, Heli Nevanlinna, Taru A. Muranen, Kristiina Aittomäki, Carl Blomqvist,
Keitaro Matsuo, Hidemi Ito, Hiroji Iwata, et al., kConFab Investigators, and Australian Ovarian
Cancer Study Group. “Fine-Scale Mapping of the FGFR2 Breast Cancer Risk Locus: Putative
Functional Variants Differentially Bind FOXA1 and E2F1.” American Journal of Human Genetics
93, no. 6 (December 5, 2013): 1046–60. doi:10.1016/j.ajhg.2013.10.026.
2012
74. Beesley, Jonathan, Xiaoqing Chen, Arto Mannermaa, Veli-Matti Kosma, Jaana M. Hartikainen,
Ylermi Soini, Douglas F. Easton, and Fergus J. Couch with Stevens, Kristen N., Zachary
Fredericksen, Celine M. Vachon, Xianshu Wang, Sara Margolin, Annika Lindblom, Heli
Nevanlinna et al., GENICA Network, Yon-Dschun Ko, Hans-Peter Fischer, Rita K. Schmutzler,
Alfons Meindl, Claus R. Bartram, Sarah Schott, Christoph Engel, et al., kConFab Investigators, and
AOCS Group. “19p13.1 Is a Triple-Negative-Specific Breast Cancer Susceptibility Locus.” Cancer
Research 72, no. 7 (April 1, 2012): 1795–1803. doi:10.1158/0008-5472.CAN-11-3364.
75. Darabi, Hatef, Kamila Czene, Wanting Zhao, Jianjun Liu, Per Hall, and Keith Humphreys. “Breast
Cancer Risk Prediction and Individualised Screening Based on Common Genetic Variation and
Breast Density Measurement.” Breast Cancer Research: BCR 14, no. 1 (2012): R25.
doi:10.1186/bcr3110.
76. Easton, Douglas F., Deborah J. Thompson, Alison M. Dunning, Paul D. P. Pharoah, Kamila Czene,
Kee Seng Chia, Per Hall, and Jianjun Liu with Li, Yuqing, Hui-Qi Low, Jia Nee Foo, Hatef Darabi,
Kristjana Einarsdόttir, Keith Humphreys, and Amanda Spurdle, ANECS Group. “Genetic Variants
in ER Cofactor Genes and Endometrial Cancer Risk.” PloS One 7, no. 8 (2012): e42445.
doi:10.1371/journal.pone.0042445.
77. Eloranta, Sandra, Paul C. Lambert, Therese M. L. Andersson, Kamila Czene, Per Hall, Magnus
Björkholm, and Paul W. Dickman. “Partitioning of Excess Mortality in Population-Based Cancer
Patient Survival Studies Using Flexible Parametric Survival Models.” BMC Medical Research
Methodology 12 (2012): 86. doi:10.1186/1471-2288-12-86.
78. Eriksson, L., P. Hall, K. Czene, I. Dos Santos Silva, V. McCormack, J. Bergh, J. Bjohle, and A.
Ploner. “Mammographic Density and Molecular Subtypes of Breast Cancer.” British Journal of
Cancer 107, no. 1 (June 26, 2012): 18–23. doi:10.1038/bjc.2012.234.
79. Eriksson, Louise, Kamila Czene, Lena Rosenberg, Keith Humphreys, and Per Hall. “The Influence
of Mammographic Density on Breast Tumor Characteristics.” Breast Cancer Research and
Treatment 134, no. 2 (July 2012): 859–66. doi:10.1007/s10549-012-2127-0.
80. Gerty, Susan M., Jorge L. Rodriguez-Gil, Graham G. Giles, Carla H. van Gils, Andrew K. Godwin,
Nikki Graham, Dario Greco et al., with Siddiq, Afshan, Fergus J. Couch, Gary K. Chen, Sara
Lindström, Diana Eccles, Robert C. Millikan, Kyriaki Michailidou et al., Australian Breast Cancer
Tissue Bank Investigators, Laura Baglietto, Elisa V. Bandera, Matthias W. Beckmann, Christine D.
Berg, Leslie Bernstein, Carl Blomqvist, Hiltrud Brauch, et al., Familial Breast Cancer Study, and
Heather Spencer Feigelson, Laura Fejerman, Jonine D. Figueroa, Olivia Fletcher, Dieter FleschJanys, and Mia M. Gaudet, GENICA Consortium. “A Meta-Analysis of Genome-Wide Association
Studies of Breast Cancer Identifies Two Novel Susceptibility Loci at 6q14 and 20q11.” Human
Molecular Genetics 21, no. 24 (December 15, 2012): 5373–84. doi:10.1093/hmg/dds381.
81. Lambrechts, Diether, Anne-Sophie Dieudonne, Sigrid Hatse, Erik van Limbergen, Javier Benitez,
Roger L. Milne, M. Pilar Zamora et al., with Fasching, Peter A., Paul D. P. Pharoah, Angela Cox,
Heli Nevanlinna, Stig E. Bojesen, Thomas Karn, Annegien Broeks, et al., kConFab Investigators.
“The Role of Genetic Breast Cancer Susceptibility Variants as Prognostic Factors.” Human
Molecular Genetics 21, no. 17 (September 1, 2012): 3926–39. doi:10.1093/hmg/dds159.
82. Lambrechts, Diether, Ann Smeets, Robert Paridaens, Caroline Weltens, Dieter Flesch-Janys,
Katharina Buck, Sabine Behrens et al., with Warren, Helen, Frank Dudbridge, Olivia Fletcher, Nick
Orr, Nichola Johnson, John L. Hopper, Carmel Apicella et al., GENICA Network, Jenny ChangClaude, Shan Wang-Gohrke, Ursula Eilber, Thilo Dörk, Peter Schürmann, Michael Bremer, Peter
Hillemanns, et al., kConFab Investigators, and Australian Ovarian Cancer Study Group. “9q31.2rs865686 as a Susceptibility Locus for Estrogen Receptor-Positive Breast Cancer: Evidence from
the Breast Cancer Association Consortium.” Cancer Epidemiology, Biomarkers & Prevention: A
Publication of the American Association for Cancer Research, Cosponsored by the American
Society of Preventive Oncology 21, no. 10 (October 2012): 1783–91. doi:10.1158/1055-9965.EPI12-0526.
83. Lambrechts, Diether, Hui Zhao, Patrick Neven, Hans Wildiers, Stefan Nickels, Dieter Flesch-Janys,
Paolo Radice et al., with Hein, Rebecca, Melanie Maranian, John L. Hopper, Miroslaw K.
Kapuscinski, Melissa C. Southey, Daniel J. Park, Marjanka K. Schmidt et al., GENICA Network,
Shan Wang-Gohrke, Thilo Dörk, Peter Schürmann, Johann H. Karstens, Peter Hillemanns, Heli
Nevanlinna, Tuomas Heikkinen, et al., Kconfab Investigators, and AOCS Group. “Comparison of
6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast
Cancer Association Consortium (BCAC).” PloS One 7, no. 8 (2012): e42380.
doi:10.1371/journal.pone.0042380.
84. Li, Jingmei, Laszlo Szekely, Louise Eriksson, Boel Heddson, Ann Sundbom, Kamila Czene, Per
Hall, and Keith Humphreys. “High-Throughput Mammographic-Density Measurement: A Tool for
Risk Prediction of Breast Cancer.” Breast Cancer Research: BCR 14, no. 4 (2012): R114.
doi:10.1186/bcr3238.
85. Menegaux, Florence, Emilie Cordina-Duverger, Chen-Yang Shen, Jyh-Cherng Yu, Pei-Ei Wu,
Ming-Feng Hou, Irene L. Andrulis et al., with Lambrechts, Diether, Therese Truong, Christina
Justenhoven, Manjeet K. Humphreys, Jean Wang, John L. Hopper, Gillian S. Dite et al., GENICA
Network, Jenny Chang-Claude, Ursel Eilber, Rebecca Hein, Stefan Nickels, Dieter Flesch-Janys,
Shan Wang-Gohrke, Esther M. John, et al., Investigators kConFab, and Australian Ovarian Cancer
Study Group. “11q13 Is a Susceptibility Locus for Hormone Receptor Positive Breast Cancer.”
Human Mutation 33, no. 7 (July 2012): 1123–32. doi:10.1002/humu.22089.
86. Muir, Kenneth R., Artitaya Lophatananon, Suthee Rattanamongkongul, Arkom Chaiwerawattana,
Daehee Kang, Keun-Young Yoo, Dong-Young Noh et al., with Ghoussaini, Maya, Olivia Fletcher,
Kyriaki Michailidou, Clare Turnbull, Marjanka K. Schmidt, Ed Dicks, Joe Dennis et al.,
Netherlands Collaborative Group on Hereditary Breast and Ovarian Cancer (HEBON), Per Hall,
Kamila Czene, Astrid Irwanto, Jianjun Liu, Heli Nevanlinna, Kristiina Aittomäki, Carl Blomqvist et
al., Familial Breast Cancer Study (FBCS), Christina Justenhoven, Hiltrud Brauch, and Thomas
Brüning, Gene Environment Interaction of Breast Cancer in Germany (GENICA) Network, Shan
Wang-Gohrke, Ursula Eilber, Thilo Dörk, Peter Schürmann, Michael Bremer, Peter Hillemanns,
Natalia V. Bogdanova, et al., kConFab Investigators, and Australian Ovarian Cancer Study Group.
“Genome-Wide Association Analysis Identifies Three New Breast Cancer Susceptibility Loci.”
Nature Genetics 44, no. 3 (March 2012): 312–18. doi:10.1038/ng.1049.
87. Neiman, Mårten, Simon Sundling, Henrik Grönberg, Per Hall, Kamila Czene, Johan Lindberg, and
Daniel Klevebring. “Library Preparation and Multiplex Capture for Massive Parallel Sequencing
Applications Made Efficient and Easy.” PloS One 7, no. 11 (2012): e48616.
doi:10.1371/journal.pone.0048616.
88. Rahman, Nazneen, and Douglas F. Easton with Varghese, Jajini S., Deborah J. Thompson, Kyriaki
Michailidou, Sara Lindström, Clare Turnbull, Judith Brown, Jean Leyland, et al., MODE
Consortium. “Mammographic Breast Density and Breast Cancer: Evidence of a Shared Genetic
Basis.” Cancer Research 72, no. 6 (March 15, 2012): 1478–84. doi:10.1158/0008-5472.CAN-113295.
89. Rosin, Gustaf, Ulf Hannelius, Linda Lindström, Per Hall, Jonas Bergh, Johan Hartman, and Juha
Kere. “The Dyslexia Candidate Gene DYX1C1 Is a Potential Marker of Poor Survival in Breast
Cancer.” BMC Cancer 12 (2012): 79. doi:10.1186/1471-2407-12-79.
90. Sandberg, Maria E. C., Per Hall, Mikael Hartman, Anna L. V. Johansson, Sandra Eloranta,
Alexander Ploner, and Kamila Czene. “Estrogen Receptor Status in Relation to Risk of Contralateral
Breast Cancer-a Population-Based Cohort Study.” PloS One 7, no. 10 (2012): e46535.
doi:10.1371/journal.pone.0046535.
91. Sandberg, Maria E. C., Mikael Hartman, Daniel Klevebring, Sandra Eloranta, Alexander Ploner, Per
Hall, and Kamila Czene. “Prognostic Implications of Estrogen Receptor Pattern of Both Tumors in
Contralateral Breast Cancer.” Breast Cancer Research and Treatment 134, no. 2 (July 2012): 793–
800. doi:10.1007/s10549-012-2096-3.
92. Stevens, Kristen N., Sara Lindstrom, Christopher G. Scott, Deborah Thompson, Thomas A. Sellers,
Xianshu Wang, Alice Wang, et al. “Identification of a Novel Percent Mammographic Density Locus
at 12q24.” Human Molecular Genetics 21, no. 14 (July 15, 2012): 3299–3305.
doi:10.1093/hmg/dds158.
93. Vachon, Celine M., Jingmei Li, Christopher G. Scott, Per Hall, Kamila Czene, Xianshu Wang,
Jianjun Liu, et al. “No Evidence for Association of Inherited Variation in Genes Involved in Mitosis
and Percent Mammographic Density.” Breast Cancer Research: BCR 14, no. 1 (2012): R7.
doi:10.1186/bcr3088.
94. Vachon, Celine M., Christopher G. Scott, Peter A. Fasching, Per Hall, Rulla M. Tamimi, Jingmei
Li, Jennifer Stone, et al. “Common Breast Cancer Susceptibility Variants in LSP1 and RAD51L1
Are Associated with Mammographic Density Measures That Predict Breast Cancer Risk.” Cancer
Epidemiology, Biomarkers & Prevention: A Publication of the American Association for Cancer
Research, Cosponsored by the American Society of Preventive Oncology 21, no. 7 (July 2012):
1156–66. doi:10.1158/1055-9965.EPI-12-0066.
95. Weischer, Maren, Børge G. Nordestgaard, Paul Pharoah, Manjeet K. Bolla, Heli Nevanlinna, Laura
J. Van’t Veer, Montserrat Garcia-Closas, et al. “CHEK2*1100delC Heterozygosity in Women with
Breast Cancer Associated with Early Death, Breast Cancer-Specific Death, and Increased Risk of a
Second Breast Cancer.” Journal of Clinical Oncology: Official Journal of the American Society of
Clinical Oncology 30, no. 35 (December 10, 2012): 4308–16. doi:10.1200/JCO.2012.42.7336.
2011
96. Biesheuvel, Cornelis, Kamila Czene, Chantal C. Orgeás, and Per Hall. “The Role of Mammography
Screening Attendance and Detection Mode in Predicting Breast Cancer Survival-Is There Added
Prognostic Value?” Cancer Epidemiology 35, no. 6 (December 2011): 545–50.
doi:10.1016/j.canep.2011.02.008.
97. Colzani, Edoardo, Annelie Liljegren, Anna L. V. Johansson, Jan Adolfsson, Henrik Hellborg, Per F.
L. Hall, and Kamila Czene. “Prognosis of Patients with Breast Cancer: Causes of Death and Effects
of Time since Diagnosis, Age, and Tumor Characteristics.” Journal of Clinical Oncology: Official
Journal of the American Society of Clinical Oncology 29, no. 30 (October 20, 2011): 4014–21.
doi:10.1200/JCO.2010.32.6462.
98. Darabi, Hatef, Kamila Czene, Sara Wedrén, Yuqing Li, Jianjun Liu, Per Hall, and Keith
Humphreys. “Genetic Variation in the Androgen Estrogen Conversion Pathway in Relation to
Breast Cancer Prognosticators.” Breast Cancer Research and Treatment 127, no. 2 (June 2011):
503–9. doi:10.1007/s10549-010-1218-z.
99. Davies, C., J. Godwin, R. Gray, M. Clarke, D. Cutter, S. Darby, P. McGale, et al. with Early Breast
Cancer Trialists’ Collaborative Group (EBCTCG). “Relevance of Breast Cancer Hormone
Receptors and Other Factors to the Efficacy of Adjuvant Tamoxifen: Patient-Level Meta-Analysis
of Randomised Trials.” Lancet (London, England) 378, no. 9793 (August 27, 2011): 771–84.
doi:10.1016/S0140-6736(11)60993-8.
100. Easton, Douglas F., and Georgia Chenevix-Trench with Milne, Roger L., Justo Lorenzo-Bermejo,
Barbara Burwinkel, Núria Malats, Jose Ignacio Arias, M. Pilar Zamora, Javier Benítez et al., AOCS
Group and Olivia Fletcher, Lorna Gibson, Isabel dos Santos Silva, Julian Peto, Bernd Frank, Joerg
Heil, Alfons Meindl, et al., GENICA Network. “7q21-rs6964587 and Breast Cancer Risk: An
Extended Case-Control Study by the Breast Cancer Association Consortium.” Journal of Medical
Genetics 48, no. 10 (October 2011): 698–702. doi:10.1136/jmedgenet-2011-100303.
101. Hillmer, Axel M., Fei Yao, Koichiro Inaki, Wah Heng Lee, Pramila N. Ariyaratne, Audrey S. M.
Teo, Xing Yi Woo, et al. “Comprehensive Long-Span Paired-End-Tag Mapping Reveals
Characteristic Patterns of Structural Variations in Epithelial Cancer Genomes.” Genome Research
21, no. 5 (May 2011): 665–75. doi:10.1101/gr.113555.110.
102. Kutschera, Simone, Holger Weber, Anja Weick, Frederik De Smet, Guillem Genove, Minoru
Takemoto, Claudia Prahst, et al. “Differential Endothelial Transcriptomics Identifies Semaphorin
3G as a Vascular Class 3 Semaphorin.” Arteriosclerosis, Thrombosis, and Vascular Biology 31, no.
1 (January 2011): 151–59. doi:10.1161/ATVBAHA.110.215871.
103. Lambrechts, Diether, Bart Claes, Thijs Vandorpe, Patrick Neven, Hans Wildiers, Dieter FleschJanys, Rebecca Hein et al., with Broeks, Annegien, Marjanka K. Schmidt, Mark E. Sherman, Fergus
J. Couch, John L. Hopper, Gillian S. Dite, Carmel Apicella et al., Genica Network, Ute Hamann,
Hans-Peter Fischer, Thomas Brüning, Beate Pesch, Jenny Chang-Claude, Shan Wang-Gohrke,
Michael Bremer, et al., kConFab, and AOCS. “Low Penetrance Breast Cancer Susceptibility Loci
Are Associated with Specific Breast Tumor Subtypes: Findings from the Breast Cancer Association
Consortium.” Human Molecular Genetics 20, no. 16 (August 15, 2011): 3289–3303.
doi:10.1093/hmg/ddr228.
104. Li, Jingmei, Keith Humphreys, Tuomas Heikkinen, Kristiina Aittomäki, Carl Blomqvist, Paul D. P.
Pharoah, Alison M. Dunning, et al. “A Combined Analysis of Genome-Wide Association Studies in
Breast Cancer.” Breast Cancer Research and Treatment 126, no. 3 (April 2011): 717–27.
doi:10.1007/s10549-010-1172-9.
105. Li, Jingmei, Petra Seibold, Jenny Chang-Claude, Dieter Flesch-Janys, Jianjun Liu, Kamila Czene,
Keith Humphreys, and Per Hall. “Coffee Consumption Modifies Risk of Estrogen-Receptor
Negative Breast Cancer.” Breast Cancer Research: BCR 13, no. 3 (2011): R49.
doi:10.1186/bcr2879.
106. Lindström, Sara, Celine M. Vachon, Jingmei Li, Jajini Varghese, Deborah Thompson, Ruth Warren,
Judith Brown, et al. “Common Variants in ZNF365 Are Associated with Both Mammographic
Density and Breast Cancer Risk.” Nature Genetics 43, no. 3 (March 2011): 185–87.
doi:10.1038/ng.760.
107. Li, Yuqing, Yi Li, Sara Wedrén, Guoliang Li, Tze Howe Charn, Kartiki Vasant Desai, Carine
Bonnard, et al. “Genetic Variation of ESR1 and Its Co-Activator PPARGC1B Is Synergistic in
Augmenting the Risk of Estrogen Receptor-Positive Breast Cancer.” Breast Cancer Research: BCR
13, no. 1 (2011): R10. doi:10.1186/bcr2817.
108. Mannermaa, Arto, Veli-Matti Kosma, Ylermi Soini, Vesa Kataja, Diether Lambrechts, Betül T.
Yesilyurt, Marie-Rose Chrisiaens et al., with Figueroa, Jonine D., Montserrat Garcia-Closas,
Manjeet Humphreys, Radka Platte, John L. Hopper, Melissa C. Southey, Carmel Apicella et al.,
GENICA Network and Jenny Chang-Claude, Rebecca Hein, Shan Wang-Gohrke, Thilo Dörk, Peter
Schürmann, Michael Bremer, Peter Hillemanns, et al., kConFab AOCS Management Group.
“Associations of Common Variants at 1p11.2 and 14q24.1 (RAD51L1) with Breast Cancer Risk and
Heterogeneity by Tumor Subtype: Findings from the Breast Cancer Association Consortium.”
Human Molecular Genetics 20, no. 23 (December 1, 2011): 4693–4706. doi:10.1093/hmg/ddr368.
109. Raines, Summer M., Oliver C. Richards, Lindsay R. Schneider, Kathryn L. Schueler, Mary E.
Rabaglia, Angie T. Oler, Donald S. Stapleton, et al. “Loss of PDGF-B Activity Increases Hepatic
Vascular Permeability and Enhances Insulin Sensitivity.” American Journal of Physiology.
Endocrinology and Metabolism 301, no. 3 (September 2011): E517–26.
doi:10.1152/ajpendo.00241.2011.
110. Salmela, Elina, Tuuli Lappalainen, Jianjun Liu, Pertti Sistonen, Peter M. Andersen, Stefan
Schreiber, Marja-Liisa Savontaus, et al. “Swedish Population Substructure Revealed by GenomeWide Single Nucleotide Polymorphism Data.” PloS One 6, no. 2 (2011): e16747.
doi:10.1371/journal.pone.0016747.
111. Tomlinson, Ian, Maggie Gorman, Kimberley Howarth, Shirley Hodgson, Montserrat Garcia-Closas,
Nicolas Wentzensen, Hannah Yang et al., with Spurdle, Amanda B., Deborah J. Thompson,
Shahana Ahmed, Kaltin Ferguson, Catherine S. Healey, Tracy O’Mara, Logan C. Walker, Stephen
B. Montgomery, and Emmanouil T. Dermitzakis, Australian National Endometrial Cancer Study
Group and Paul Fahey, Grant W. Montgomery, Penelope M. Webb, Peter A. Fasching, Matthias W.
Beckmann, Arif B. Ekici, Alexander Hein, et al., National Study of Endometrial Cancer Genetics
Group. “Genome-Wide Association Study Identifies a Common Variant Associated with Risk of
Endometrial Cancer.” Nature Genetics 43, no. 5 (May 2011): 451–54. doi:10.1038/ng.812.
112. Webb, Penelope M., and Amanda B. Spurdle with O’Mara, Tracy A., Paul Fahey, Kaltin Ferguson,
Louise Marquart, Diether Lambrechts, Evelyn Despierre, Ignace Vergote, et al., SASBAC, Timothy
R. Rebbeck, WISE Study Group, AOCS Management Group, SEARCH, and Shahana Ahmed,
Alison M. Dunning, Catherine S. Gregory, and Mitul Shah, ANECS. “Progesterone Receptor Gene
Variants and Risk of Endometrial Cancer.” Carcinogenesis 32, no. 3 (March 2011): 331–35.
doi:10.1093/carcin/bgq263.
113. Yang, Xiaohong R., Jenny Chang-Claude, Ellen L. Goode, Fergus J. Couch, Heli Nevanlinna, Roger
L. Milne, Mia Gaudet, et al. “Associations of Breast Cancer Risk Factors with Tumor Subtypes: A
Pooled Analysis from the Breast Cancer Association Consortium Studies.” Journal of the National
Cancer Institute 103, no. 3 (February 2, 2011): 250–63. doi:10.1093/jnci/djq526.
2010
114. Armulik, Annika, Guillem Genové, Maarja Mäe, Maya H. Nisancioglu, Elisabet Wallgard, Colin
Niaudet, Liqun He, et al. “Pericytes Regulate the Blood-Brain Barrier.” Nature 468, no. 7323
(November 25, 2010): 557–61. doi:10.1038/nature09522.
115. Beesley, Jonathan, Xiaoqing Chen, Georgia Chenevix-Trench, Fergus J. Couch, Janet E. Olson,
Zachary S. Fredericksen, Xianshu Wang et al., with Azzato, Elizabeth M., Jonathan Tyrer, Peter A.
Fasching, Matthias W. Beckmann, Arif B. Ekici, Rüdiger Schulz-Wendtland, Stig E. Bojesen, et al.,
Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer.
“Association between a Germline OCA2 Polymorphism at Chromosome 15q13.1 and Estrogen
Receptor-Negative Breast Cancer Survival.” Journal of the National Cancer Institute 102, no. 9
(May 5, 2010): 650–62. doi:10.1093/jnci/djq057.
116. Fletcher, Olivia, Nichola Johnson, Isabel dos Santos Silva, Nick Orr, Alan Ashworth, Heli
Nevanlinna, Tuomas Heikkinen et al., kConFab Investigators, AOCS Group, Jonathan Beesley,
Natalia V. Bogdanova, Natalia N. Antonenkova, Iosif V. Zalutsky, Hoda Anton-Culver, Argyrios
Ziogas, Hiltrud Brauch, Yon-Dschun Ko, and Ute Hamann, GENICA Consortium, and Peter A.
Fasching, Reiner Strick, Arif B. Ekici, Matthias W. Beckmann, Graham G. Giles, Gianluca Severi,
Laura Baglietto, et al., Breast Cancer Association Consortium. “Missense Variants in ATM in
26,101 Breast Cancer Cases and 29,842 Controls.” Cancer Epidemiology, Biomarkers &
Prevention: A Publication of the American Association for Cancer Research, Cosponsored by the
American Society of Preventive Oncology 19, no. 9 (September 2010): 2143–51. doi:10.1158/10559965.EPI-10-0374.
117. Giles, Graham G., Laura Baglietto, Gianluca Severi, Stig E. Bojensen, Børge G. Nordestgaard,
Henrik Flyger, Esther M. John et al., with Milne, Roger L., Mia M. Gaudet, Amanda B. Spurdle,
Peter A. Fasching, Fergus J. Couch, Javier Benítez, José Ignacio Arias Pérez, et al., GENICA
Network, Diether Lambrechts, Joke Reumers, Ann Smeets, Shan Wang-Gohrke, Per Hall, Kamila
Czene, Jianjun Liu, Astrid K. Irwanto, Georgia Chenevix-Trench, and Helene Holland, kConFab,
and AOCS. “Assessing Interactions between the Associations of Common Genetic Susceptibility
Variants, Reproductive History and Body Mass Index with Breast Cancer Risk in the Breast Cancer
Association Consortium: A Combined Case-Control Study.” Breast Cancer Research: BCR 12, no.
6 (2010): R110. doi:10.1186/bcr2797.
118. Hagberg, Carolina E., Annelie Falkevall, Xun Wang, Erik Larsson, Jenni Huusko, Ingrid Nilsson,
Laurens A. van Meeteren, et al. “Vascular Endothelial Growth Factor B Controls Endothelial Fatty
Acid Uptake.” Nature 464, no. 7290 (April 8, 2010): 917–21. doi:10.1038/nature08945.
119. Hägglöf, Christina, Peter Hammarsten, Andreas Josefsson, Pär Stattin, Janna Paulsson, Anders
Bergh, and Arne Ostman. “Stromal PDGFRbeta Expression in Prostate Tumors and Non-Malignant
Prostate Tissue Predicts Prostate Cancer Survival.” PloS One 5, no. 5 (2010): e10747.
doi:10.1371/journal.pone.0010747.
120. Khoshnoud, Reza, Qimin He, Maria Sylván, Aida Khoshnoud, Madleen Ivarsson, Tommy
Fornander, Jonas Bergh, Jan Frisell, Lars-Erik Rutqvist, and Sven Skog. “The Impact of RNA
Standardization and Heterogeneous Gene Expression on the Results of cDNA Array of Human
Breast Carcinoma.” International Journal of Molecular Medicine 25, no. 5 (May 2010): 735–41.
121. Li, Jingmei, Louise Eriksson, Keith Humphreys, Kamila Czene, Jianjun Liu, Rulla M. Tamimi, Sara
Lindström, et al. “Genetic Variation in the Estrogen Metabolic Pathway and Mammographic
Density as an Intermediate Phenotype of Breast Cancer.” Breast Cancer Research: BCR 12, no. 2
(2010): R19. doi:10.1186/bcr2488.
122. Li, Jingmei, Keith Humphreys, Hatef Darabi, Gustaf Rosin, Ulf Hannelius, Tuomas Heikkinen,
Kristiina Aittomäki, et al. “A Genome-Wide Association Scan on Estrogen Receptor-Negative
Breast Cancer.” Breast Cancer Research: BCR 12, no. 6 (2010): R93. doi:10.1186/bcr2772.
123. Li, Jingmei, Keith Humphreys, Louise Eriksson, Kamila Czene, Jianjun Liu, and Per Hall. “Effects
of Childhood Body Size on Breast Cancer Tumour Characteristics.” Breast Cancer Research: BCR
12, no. 2 (2010): R23. doi:10.1186/bcr2564.
124. Low, Yen Ling, Yuqing Li, Keith Humphreys, Anbupalam Thalamuthu, Yi Li, Hatef Darabi, Sara
Wedrén, et al. “Multi-Variant Pathway Association Analysis Reveals the Importance of Genetic
Determinants of Estrogen Metabolism in Breast and Endometrial Cancer Susceptibility.” PLoS
Genetics 6, no. 7 (July 2010): e1001012. doi:10.1371/journal.pgen.1001012.
125. Mahmoudi, Salah, Sofia Henriksson, Irene Weibrecht, Stephen Smith, Ola Söderberg, Staffan
Strömblad, Klas G. Wiman, and Marianne Farnebo. “WRAP53 Is Essential for Cajal Body
Formation and for Targeting the Survival of Motor Neuron Complex to Cajal Bodies.” PLoS
Biology 8, no. 11 (2010): e1000521. doi:10.1371/journal.pbio.1000521.
126. ———. “WRAP53 Is Essential for Cajal Body Formation and for Targeting the Survival of Motor
Neuron Complex to Cajal Bodies.” PLoS Biology 8, no. 11 (2010): e1000521.
doi:10.1371/journal.pbio.1000521.
127. Nisancioglu, Maya H., Christer Betsholtz, and Guillem Genové. “The Absence of Pericytes Does
Not Increase the Sensitivity of Tumor Vasculature to Vascular Endothelial Growth Factor-A
Blockade.” Cancer Research 70, no. 12 (June 15, 2010): 5109–15. doi:10.1158/0008-5472.CAN09-4245.
128. Sandberg, Maria E. C., Mikael Hartman, Gustaf Edgren, Sandra Eloranta, Alexander Ploner, Per
Hall, and Kamila Czene. “Diagnostic Work-up of Contralateral Breast Cancers Has Not Improved
over Calendar Period.” Breast Cancer Research and Treatment 122, no. 3 (August 2010): 889–95.
doi:10.1007/s10549-010-0748-8.
129. Tamimi, Rulla M., Louise Eriksson, Pagona Lagiou, Kamila Czene, Anders Ekbom, Chung-Cheng
Hsieh, Hans-Olov Adami, Dimitrios Trichopoulos, and Per Hall. “Birth Weight and Mammographic
Density among Postmenopausal Women in Sweden.” International Journal of Cancer. Journal
International Du Cancer 126, no. 4 (February 15, 2010): 985–91. doi:10.1002/ijc.24786.
130. Tamimi, Rulla M., Pagona Lagiou, Kamila Czene, Jianjun Liu, Anders Ekbom, Chung-Cheng
Hsieh, Hans-Olov Adami, Dimitrios Trichopoulos, and Per Hall. “Birth Weight, Breast Cancer
Susceptibility Loci, and Breast Cancer Risk.” Cancer Causes & Control: CCC 21, no. 5 (May
2010): 689–96. doi:10.1007/s10552-009-9496-7.
131. Tennis, M., B. Singh, A. Hjerpe, M. Prochazka, K. Czene, P. Hall, and P. G. Shields. “Pathological
Confirmation of Primary Lung Cancer Following Breast Cancer.” Lung Cancer (Amsterdam,
Netherlands) 69, no. 1 (July 2010): 40–45. doi:10.1016/j.lungcan.2009.08.018.
Reviews and book chapters (8)
1.
Armulik, Annika, Guillem Genové, and Christer Betsholtz. “Pericytes: Developmental,
Physiological, and Pathological Perspectives, Problems, and Promises.” Developmental Cell 21, no.
2 (August 16, 2011): 193–215. doi:10.1016/j.devcel.2011.07.001.
2.
Bergh, J., P. Hall, A. Östman, and R. Toftgård. “Breast Cancer Biology and the Future of Tailored
Therapies. Introduction.” Journal of Internal Medicine 274, no. 2 (August 2013): 102–4.
doi:10.1111/joim.12101.
3.
Correa, C., P. McGale, C. Taylor, Y. Wang, M. Clarke, C. Davies, R. Peto, N. Bijker, L. Solin, and
S. Darby with Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). “Overview of the
Randomized Trials of Radiotherapy in Ductal Carcinoma in Situ of the Breast.” Journal of the
National Cancer Institute. Monographs 2010, no. 41 (2010): 162–77.
doi:10.1093/jncimonographs/lgq039.
4.
Darby, S., P. McGale, C. Correa, C. Taylor, R. Arriagada, M. Clarke, D. Cutter, et al. with Early
Breast Cancer Trialists’ Collaborative Group (EBCTCG). “Effect of Radiotherapy after BreastConserving Surgery on 10-Year Recurrence and 15-Year Breast Cancer Death: Meta-Analysis of
Individual Patient Data for 10,801 Women in 17 Randomised Trials.” Lancet (London, England)
378, no. 9804 (November 12, 2011): 1707–16. doi:10.1016/S0140-6736(11)61629-2.
5.
Ostman, Arne, and Kristian Pietras. “Introduction to Tumor-Stroma Interactions.” Experimental
Cell Research 319, no. 11 (July 1, 2013): 1595. doi:10.1016/j.yexcr.2013.05.026.
6.
Pietras, Kristian, and Arne Ostman. “Hallmarks of Cancer: Interactions with the Tumor Stroma.”
Experimental Cell Research 316, no. 8 (May 1, 2010): 1324–31. doi:10.1016/j.yexcr.2010.02.045.
7.
Saeed, Ahmed A., Guillem Genové, Tian Li, Frank Hülshorst, Christer Betsholtz, Ingemar
Björkhem, and Dieter Lütjohann. “Increased Flux of the Plant Sterols Campesterol and Sitosterol
across a Disrupted Blood Brain Barrier.” Steroids 99, no. Pt B (July 2015): 183–88.
doi:10.1016/j.steroids.2015.02.005.
8.
Weiland, A., P. Roswall, T. C. Hatzihristidis, K. Pietras, A. Ostman, and C. Strell. “FibroblastDependent Regulation of the Stem Cell Properties of Cancer Cells.” Neoplasma 59, no. 6 (2012):
719–27. doi:10.4149/neo_2012_091.